Elevance Health Ownership
| ELV Stock | USD 430.48 5.77 1.32% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Elevance |
Elevance Stock Ownership Analysis
About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Elevance Health was currently reported as 181.62. The company has Price/Earnings To Growth (PEG) ratio of 0.94. Elevance Health recorded earning per share (EPS) of 25.7. The entity last dividend was issued on the 10th of March 2025. The firm had 2:1 split on the 1st of June 2005. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. Elevance Health operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 98200 people. To learn more about Elevance Health call Gail Boudreaux at 833 401 1577 or check out https://www.elevancehealth.com.Elevance Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevance Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevance Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevance Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ronald Penczek over three months ago Disposition of 1055 shares by Ronald Penczek of Elevance Health at 475.17 subject to Rule 16b-3 | ||
Blair Todt over three months ago Disposition of 7 shares by Blair Todt of Elevance Health at 480.49 subject to Rule 16b-3 | ||
Peru Ramiro G over six months ago Disposition of 753 shares by Peru Ramiro G of Elevance Health at 531.52 subject to Rule 16b-3 | ||
Neri Antonio F over six months ago Acquisition by Neri Antonio F of 388 shares of Elevance Health subject to Rule 16b-3 | ||
Ronald Penczek over six months ago Disposition of tradable shares by Ronald Penczek of Elevance Health at 454.35 subject to Rule 16b-3 | ||
Schneider Ryan M. over six months ago Acquisition by Schneider Ryan M. of 457 shares of Elevance Health subject to Rule 16b-3 | ||
Charles Kendrick over six months ago Acquisition by Charles Kendrick of 7786 shares of Elevance Health at 469.03 subject to Rule 16b-3 | ||
Zielinski Thomas C over a year ago Sale by Zielinski Thomas C of 5254 shares of Elevance Health |
Elevance Health's latest congressional trading
Congressional trading in companies like Elevance Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Elevance Health by those in governmental positions are based on the same information available to the general public.
| 2025-03-10 | Representative Jefferson Shreve | Acquired $15K to $50K | Verify | ||
| 2025-02-14 | Representative Rob Bresnahan | Acquired Under $15K | Verify | ||
| 2025-02-07 | Senator John Fetterman | Acquired Under $15K | Verify | ||
| 2024-12-18 | Representative Michael McCaul | Acquired $15K to $50K | Verify | ||
| 2024-12-09 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-09-02 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-08-06 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-11 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify |
Elevance Health Outstanding Bonds
Elevance Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elevance Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elevance bonds can be classified according to their maturity, which is the date when Elevance Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US03674XAS53 Corp BondUS03674XAS53 | View | |
| US03674XAQ97 Corp BondUS03674XAQ97 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| ANTHEM INC Corp BondUS036752AN31 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.